Jennifer E. Gerber

859 total citations
19 papers, 560 citations indexed

About

Jennifer E. Gerber is a scholar working on Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Jennifer E. Gerber has authored 19 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Health, 6 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Jennifer E. Gerber's work include Vaccine Coverage and Hesitancy (7 papers), Influenza Virus Research Studies (3 papers) and Cervical Cancer and HPV Research (3 papers). Jennifer E. Gerber is often cited by papers focused on Vaccine Coverage and Hesitancy (7 papers), Influenza Virus Research Studies (3 papers) and Cervical Cancer and HPV Research (3 papers). Jennifer E. Gerber collaborates with scholars based in United States, Canada and United Kingdom. Jennifer E. Gerber's co-authors include Kurt J. Isselbacher, W. P. T. James, David Alpers, Gavin Giovannoni, S V Ramagopalan, Jina Pakpoor, Giulio Disanto, Ute‐Christiane Meier, Gypsyamber DʼSouza and Robert I. Haddad and has published in prestigious journals such as Journal of Clinical Oncology, Biological Psychiatry and Vaccine.

In The Last Decade

Jennifer E. Gerber

17 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer E. Gerber United States 10 127 120 113 113 104 19 560
Noah D. Peyser United States 13 39 0.3× 40 0.3× 123 1.1× 190 1.7× 35 0.3× 22 738
Jordan C. Stern United States 16 67 0.5× 251 2.1× 9 0.1× 174 1.5× 33 0.3× 25 861
Duk-Hyoung Lee South Korea 10 127 1.0× 7 0.1× 45 0.4× 223 2.0× 46 0.4× 16 690
Derry Ridgway United States 15 100 0.8× 10 0.1× 16 0.1× 179 1.6× 30 0.3× 36 797
Diogo Alpuim Costa Portugal 11 26 0.2× 47 0.4× 8 0.1× 129 1.1× 15 0.1× 46 373
Witold Kędzia Poland 17 324 2.6× 12 0.1× 7 0.1× 172 1.5× 26 0.3× 163 961
Nikolaοs Goutas Greece 14 45 0.4× 13 0.1× 6 0.1× 153 1.4× 33 0.3× 46 499
Calvin James United States 12 64 0.5× 17 0.1× 8 0.1× 99 0.9× 6 0.1× 21 428
Laura M. Tanner Finland 14 117 0.9× 4 0.0× 11 0.1× 52 0.5× 50 0.5× 34 602
Charles P. Dzamalala Malawi 15 149 1.2× 4 0.0× 13 0.1× 308 2.7× 56 0.5× 26 826

Countries citing papers authored by Jennifer E. Gerber

Since Specialization
Citations

This map shows the geographic impact of Jennifer E. Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Gerber more than expected).

Fields of papers citing papers by Jennifer E. Gerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Gerber. The network helps show where Jennifer E. Gerber may publish in the future.

Co-authorship network of co-authors of Jennifer E. Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Gerber. A scholar is included among the top collaborators of Jennifer E. Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Gerber. Jennifer E. Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cueva, Ignacio Salamanca de la, Jennifer E. Gerber, Carlos Brotons, et al.. (2024). Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season. Drug Safety. 47(11). 1137–1148.
2.
Dudley, Matthew Z., Benjamin Schwartz, Janesse Brewer, et al.. (2023). COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021. Vaccine. 41(49). 7395–7408. 2 indexed citations
3.
Dudley, Matthew Z., Jennifer E. Gerber, Taylor A. Holroyd, et al.. (2023). Vaccinomics: A scoping review. Vaccine. 41(14). 2357–2367. 4 indexed citations
4.
Dudley, Matthew Z., Benjamin Schwartz, Janesse Brewer, et al.. (2022). COVID-19 Vaccination Status, Attitudes, and Values among US Adults in September 2021. Journal of Clinical Medicine. 11(13). 3734–3734. 13 indexed citations
5.
Gerber, Jennifer E., et al.. (2021). Genomics in Patient Care and Workforce Decisions in High-Level Isolation Units: A Survey of Healthcare Workers. Health Security. 19(3). 318–326. 1 indexed citations
6.
Salmon, Daniel A., Matthew Z. Dudley, Janesse Brewer, et al.. (2021). COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization. Vaccine. 39(19). 2698–2711. 79 indexed citations
7.
Gerber, Jennifer E., et al.. (2021). Ethical and policy implications of vaccinomics in the United States: community members’ perspectives. Human Vaccines & Immunotherapeutics. 17(7). 2133–2144. 5 indexed citations
8.
Holroyd, Taylor A., Rupali J. Limaye, Jennifer E. Gerber, et al.. (2021). Development of a Scale to Measure Trust in Public Health Authorities: Prevalence of Trust and Association with Vaccination. Journal of Health Communication. 26(4). 272–280. 26 indexed citations
9.
Gerber, Jennifer E., Janesse Brewer, Rupali J. Limaye, et al.. (2021). Vaccinomics: a cross-sectional survey of public values. Human Vaccines & Immunotherapeutics. 17(9). 2999–3015. 2 indexed citations
10.
DʼSouza, Gypsyamber, Yuehan Zhang, Samantha Merritt, et al.. (2016). Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer. Oral Oncology. 60. 90–95. 26 indexed citations
11.
Anderson, Karen S., Jennifer E. Gerber, Gypsyamber DʼSouza, et al.. (2015). Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study. Oral Oncology. 51(8). 751–758. 29 indexed citations
12.
DʼSouza, Gypsyamber, Neil D. Gross, Sara I. Pai, et al.. (2014). Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners. Journal of Clinical Oncology. 32(23). 2408–2415. 109 indexed citations
13.
Pakpoor, Jina, Giulio Disanto, Jennifer E. Gerber, et al.. (2012). The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Multiple Sclerosis Journal. 19(2). 162–166. 126 indexed citations
14.
Jimerson, David C., et al.. (1993). Response to SSRI antidepressants correlates with reduction in plasma HVA: Pilot study. Biological Psychiatry. 34(8). 569–571. 12 indexed citations
15.
Gerber, Jennifer E., et al.. (1988). Microheterogeneity of alpha 1-acid glycoprotein in the sera of patients with cancer or inflammatory states of the ovaries.. PubMed. 36(1). 1–6. 7 indexed citations
16.
Gerber, Jennifer E., et al.. (1987). Affino-immunoelectrophoresis of haptoglobin with wheat germ agglutinin. Diagnostic significance in ovarian carcinoma.. PubMed. 35(4). 547–52. 5 indexed citations
17.
Gerber, Jennifer E., et al.. (1983). Eccrine spiradenoma and dermal cylindroma. Journal of Cutaneous Pathology. 10(1). 73–78. 14 indexed citations
18.
James, W. P. T., David Alpers, Jennifer E. Gerber, & Kurt J. Isselbacher. (1971). The turnover of disaccharidases and brush border proteins in rat intestine. Biochimica et Biophysica Acta (BBA) - General Subjects. 230(2). 194–203. 99 indexed citations
19.
Jablonski, Kathleen, et al.. (1969). [Extensive vaginal ulcerations due to self mutilation].. PubMed. 22(4). 407–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026